快照:针对大脑的抗肥胖药物
Jonas Petersen1, Valdemar Brimnes Ingemann Johansen1, Christoffer Clemmensen1
1Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
Cell metabolism
|March 5, 2025
概括
新的减肥药物,包括GLP-1受体激动剂,为肥胖提供安全有效的治疗方法. 这些进展为治疗心脏代谢疾病和其他慢性健康状况提供了巨大的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 神经生物学 神经生物学 神经生物学
- 药用化学 医学化学
背景情况:
- 对体重调节和食欲神经生物学的理解有了显著的进步.
- 药物化学的创新使得新的治疗剂的开发成为可能.
研究的目的:
- 审查安全有效的减肥药物的最新进展.
- 突出GLP-1受体激动剂和相关疗法在治疗肥胖和心脏代谢疾病方面的潜力.
主要方法:
- 关于肥胖,食欲调节和药物治疗的最新科学文献的综述.
- 分析GLP-1受体激动剂和多激动剂的机制和临床应用.
主要成果:
- 长效GLP-1受体激动剂已经改变了肥胖治疗模式.
- 新兴的基于GLP-1的多抗激素剂和组合疗法显示出更广泛应用的前景.
结论:
- 了解和治疗方面的进步为管理肥胖和相关疾病提供了新的希望.
- 基于GLP-1的疗法代表了重要的治疗进步,有可能影响多种慢性疾病.
相关概念视频
Targets for Drug Action: Overview
9.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.4K
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
Brain Imaging
1.0K
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
1.0K


